A systems biology view of blood vessel growth and remodelling

EA Logsdon, SD Finley, AS Popel… - Journal of cellular and …, 2014 - Wiley Online Library
Blood travels throughout the body in an extensive network of vessels–arteries, veins and
capillaries. This vascular network is not static, but instead dynamically remodels in response …

[HTML][HTML] Seek & Destroy, use of targeting peptides for cancer detection and drug delivery

V Le Joncour, P Laakkonen - Bioorganic & medicinal chemistry, 2018 - Elsevier
Accounting for 16 million new cases and 9 million deaths annually, cancer leaves a great
number of patients helpless. It is a complex disease and still a major challenge for the …

Matrikines from basement membrane collagens: a new anti-cancer strategy

JC Monboisse, JB Oudart, L Ramont… - … et Biophysica Acta (BBA …, 2014 - Elsevier
Background Tumor microenvironment is a complex system composed of a largely altered
extracellular matrix with different cell types that determine angiogenic responses and tumor …

Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis

K Jin, NB Pandey, AS Popel - Breast Cancer Research, 2018 - Springer
Background Metastatic triple-negative breast cancer (TNBC) is a heterogeneous and
incurable disease. Numerous studies have been conducted to seek molecular targets to …

Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment

E Lee, NB Pandey, AS Popel - Expert reviews in molecular medicine, 2015 - cambridge.org
Tumour and organ microenvironments are crucial for cancer progression and metastasis.
Crosstalk between multiple non-malignant cell types in the microenvironments and cancer …

Gene delivery nanoparticles to modulate angiogenesis

J Kim, AC Mirando, AS Popel, JJ Green - Advanced drug delivery reviews, 2017 - Elsevier
Angiogenesis is naturally balanced by many pro-and anti-angiogenic factors while an
imbalance of these factors leads to aberrant angiogenesis, which is closely associated with …

Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling

BNP Kumar, S Rajput, KK Dey, A Parekh, S Das… - Bmc Cancer, 2013 - Springer
Background Tamoxifen (TAM) is widely used in the chemotherapy of breast cancer and as a
preventive agent against recurrence after surgery. However, extended TAM administration …

Computational systems biology approaches to anti-angiogenic cancer therapeutics

SD Finley, LH Chu, AS Popel - Drug discovery today, 2015 - Elsevier
Highlights•Systems biology approaches support drug development efforts.•Models of
angiogenesis aid in testing anti-angiogenic therapeutic strategies.•Models provide novel …

Synergistic effect of the pro-apoptosis peptide kla-TAT and the cationic anticancer peptide HPRP-A1

C Hu, X Chen, Y Huang, Y Chen - Apoptosis, 2018 - Springer
In this study, a peptide–peptide co-administration therapy between hybrid peptide kla-TAT
and cationic anticancer peptide HPRP-A1 was designed to increase the anticancer activity …

Inhibition of breast cancer growth and metastasis by a biomimetic peptide

E Lee, SJ Lee, JE Koskimaki, Z Han, NB Pandey… - Scientific reports, 2014 - nature.com
Metastasis is the main cause of mortality in cancer patients. Though there are many anti-
cancer drugs targeting primary tumor growth, anti-metastatic agents are rarely developed …